STRUCTURAL CHARACTERIZATION OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN
炭疽毒素保护性抗原的结构表征
基本信息
- 批准号:8359660
- 负责人:
- 金额:$ 26.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-04-01 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:Anthrax diseaseAntigen ReceptorsAntigensBindingBioterrorismCircular Dichroism SpectroscopyDevelopmentFluorescenceFundingGrantHistidineInfectionMembraneMethodsNational Center for Research ResourcesPrincipal InvestigatorProteinsResearchResearch InfrastructureResourcesSideSolutionsSourceStagingStructureTherapeuticUnited States National Institutes of Healthanthrax toxinbasecostcytotoxicityprotein structureprotein structure functionprotonationreceptorreceptor bindingresearch studysolid state nuclear magnetic resonancetherapy development
项目摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
The ongoing threat of the use of anthrax as a bioterrorism agent necessitates the development of therapies that block the action of anthrax toxin at any stage of infection. The objective of this research is to understand how pH governs the large conformational change in the protective antigen (PA) to form a membrane spanning pore, a requisite step to initiating the cytotoxicity associated with anthrax, which will guide the development of effective therapeutics directed against anthrax infection. The specific hypothesis is that formation of a pore in the presence of the receptor is critically dependent on the protonation of one or more specific histidine residues. Support for this hypothesis derives from results of preliminary experiments which show that the uniform biosynthetic incorporation of 2-fluorohistidine (2-FHis) (which has a dramatically lower side-chain pKa (pKa ~1)) into the heptamer of PA results in a multimeric protein structure that cannot undergo the pH dependent changes leading to a pore. Our specific aims are to:
1. Determine the structural basis by which the receptor modulates pore formation. Based on preliminary results, we hypothesize that protonation of histidine residues specifically in the PA receptor binding domain (domain 4) causes a conformational change that results in a loss of binding to the receptor. We plan to isolate and characterize the structure of the receptor binding domain of PA using biophysical methods, including fluorescence, circular dichroism spectroscopy and NMR.
2. Identify specific regions within PA that undergo pH-dependent structural changes that result in pore formation. In addition to the known structural changes that occur in domain 2 of PA, structural changes are likely to occur throughout the protein that are required to facilitate the correct formation of a functional pore. How these structural changes are dependent upon pH will be determined using solution ([13C] and [19F]) and solid-state NMR.
该副本是利用资源的众多研究子项目之一
由NIH/NCRR资助的中心赠款提供。对该子弹的主要支持
而且,副投影的主要研究员可能是其他来源提供的
包括其他NIH来源。 列出的总费用可能
代表subproject使用的中心基础架构的估计量,
NCRR赠款不直接向子弹或副本人员提供的直接资金。
使用炭疽作为生物恐怖剂的持续威胁需要开发疗法,以阻止在任何感染阶段的炭疽毒素作用。这项研究的目的是了解pH如何控制保护性抗原(PA)形成膜毛孔的巨大构象变化,这是启动与炭疽相关的细胞毒性的必要步骤,这将指导针对抗炭疽感染的有效治疗剂的发展。具体假设是,在受体存在下形成孔的形成取决于一个或多个特定的组氨酸残基的质子化。对这一假设的支持来自初步实验的结果,这些实验表明,2-氟化鼠(2-FHIS)的均匀生物合成掺入(其在多上蛋白质结构中,PA的heptamer均无法使pH依赖性变化,这使PA的hepTamer均在PA的hepTAMER中具有较低的侧链PKA(PKA〜1)的显着下降。我们的具体目的是:
1。确定受体调节孔形成的结构基础。基于初步结果,我们假设组氨酸残基在PA受体结合结构域(结构域4)的质子化会导致构象变化,从而导致与受体结合的丧失。我们计划使用生物物理方法(包括荧光,圆形二色性光谱和NMR)分离和表征PA受体结合结构域的结构。
2。确定PA内经历pH依赖性结构变化的特定区域,从而导致孔形成。除了PA的域2中发生的已知结构变化外,在整个蛋白质中可能会发生结构变化,以促进功能孔的正确形成。这些结构变化如何取决于pH,使用溶液([13C]和[19F])和固态NMR确定。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James G. Bann其他文献
James G. Bann的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('James G. Bann', 18)}}的其他基金
STRUCTURAL CHARACTERIZATION OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN
炭疽毒素保护性抗原的结构表征
- 批准号:
8167404 - 财政年份:2010
- 资助金额:
$ 26.11万 - 项目类别:
STRUCTURAL CHARACTERIZATION OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN
炭疽毒素保护性抗原的结构表征
- 批准号:
7959516 - 财政年份:2009
- 资助金额:
$ 26.11万 - 项目类别:
STRUCTURE AND MECHANISM OF CS1 PILUS ASSEMBLY
CS1 PILUS组件的结构和机构
- 批准号:
7720683 - 财政年份:2008
- 资助金额:
$ 26.11万 - 项目类别:
STRUCTURE AND MECHANISM OF CS1 PILUS ASSEMBLY
CS1 PILUS组件的结构和机构
- 批准号:
7381967 - 财政年份:2006
- 资助金额:
$ 26.11万 - 项目类别:
STRUCTURE AND MECHANISM OF CS1 PILUS ASSEMBLY
CS1 PILUS组件的结构和机构
- 批准号:
6981861 - 财政年份:2004
- 资助金额:
$ 26.11万 - 项目类别:
相似国自然基金
嵌合抗原受体巨噬细胞(CAR-M)微马达的制备及其血管蜂窝网络磁驱行为机理与控制方法研究
- 批准号:52375565
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
体内构建嵌合抗原受体Kupffer细胞(CAR-KC)并借助“细胞变装”策略实现肝癌双靶杀伤
- 批准号:82304398
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
双靶向CSPG4/CD126嵌合抗原受体修饰的复制缺失型弓形虫减毒活疫苗(CAR-Tg)抗恶性黑色素瘤的效应及机制研究
- 批准号:32370997
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
靶向c-MET以及CD133的串联双靶点嵌合抗原受体—巨噬细胞(CAR-M)对胰腺癌的杀伤及化疗协同增效作用及机制研究
- 批准号:82373230
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
脂质纳米粒体内介导嵌合抗原受体-M1型巨噬细胞协同TLR激动剂治疗实体瘤的研究
- 批准号:82304418
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax
人类炭疽病病理学的分子和免疫学分析
- 批准号:
10239273 - 财政年份:2020
- 资助金额:
$ 26.11万 - 项目类别:
Rapid Generation of Vaccine Candidates Against Novel Coronavirus (SARS-CoV-2) Using the Bacteriophage T4 Nanoparticle Platform
使用噬菌体 T4 纳米颗粒平台快速生成针对新型冠状病毒 (SARS-CoV-2) 的候选疫苗
- 批准号:
10265803 - 财政年份:2020
- 资助金额:
$ 26.11万 - 项目类别:
Virus-Like Nanoparticles for Non-Capsid Antigen Delivery with Virus Structure/Functional Mimicry to Activate B Cell Immunity
用于非衣壳抗原递送的病毒样纳米颗粒,具有病毒结构/功能拟态以激活 B 细胞免疫
- 批准号:
10044823 - 财政年份:2020
- 资助金额:
$ 26.11万 - 项目类别:
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax
人类炭疽病病理学的分子和免疫学分析
- 批准号:
10264258 - 财政年份:2020
- 资助金额:
$ 26.11万 - 项目类别:
Targeted-delivery of small interference RNA against anthrax (1 R21 AI118228-01A1)
针对炭疽病的小干扰 RNA 的靶向递送(1 R21 AI118228-01A1)
- 批准号:
9152506 - 财政年份:2016
- 资助金额:
$ 26.11万 - 项目类别: